Immuneering (IMRX) Receivables - Net (2020 - 2023)

Immuneering (IMRX) posted quarterly Receivables - Net of $1046.0 for Q1 2023, down 99.63% year-over-year from $279614.0 in Q1 2022, and down 91.58% quarter-over-quarter from $12417.0 in Q4 2022.

Immuneering (IMRX) Receivables - Net (2020 - 2023) Analysis & Trends

Immuneering's Receivables - Net history runs 4 years deep, the most recent figure standing at $1046.0 for Q1 2023.

  • In Q1 2023, Receivables - Net fell 99.63% year-over-year to $1046.0; the TTM figure through Mar 2023 stood at $1046.0 (down 99.63% YoY), while the FY2022 annual figure was $12417.0, down 94.95% from the prior year.
  • Receivables - Net for Q1 2023 stood at $1046.0, down from $12417.0 in the prior quarter.
  • The five-year high for Receivables - Net was $500110.0 in Q4 2020, with the low at $1046.0 in Q1 2023.
  • The 4-year median for Receivables - Net is $246040.0 (2021), against an average of $250479.1.
  • The sharpest annual moves came in 2021 and 2023: Receivables - Net slumped 50.8% in 2021, then plunged 99.63% in 2023.
  • Immuneering's Receivables - Net stood at $500110.0 in 2020, then plunged by 50.8% to $246040.0 in 2021, then sank by 94.95% to $12417.0 in 2022, then slumped by 91.58% to $1046.0 in 2023.
  • Business Quant data shows IMRX's Receivables - Net at $1046.0 in Q1 2023, $12417.0 in Q4 2022, and $70180.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Immuneering 327.37 Mn 327.37 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2023 1,046.00
Mar 31, 2023 1,046.00
Dec 31, 2022 12,417.00
Dec 31, 2022 12,417.00
Sep 30, 2022 70,180.00
Sep 30, 2022 70,180.00
Jun 30, 2022 178,425.00
Jun 30, 2022 178,425.00
Mar 31, 2022 279,614.00
Mar 31, 2022 279,614.00
Dec 31, 2021 246,040.00
Dec 31, 2021 246,040.00
Sep 30, 2021 471,375.00
Sep 30, 2021 471,375.00
Jun 30, 2021 495,105.00
Jun 30, 2021 495,105.00
Dec 31, 2020 500,110.00
Dec 31, 2020 500,110.00